CD34 and leukemia: In these previous studies, although CD34+ hematopoietic stem cells were mobilized and isolated from HLA-mismatched donors and infused into the recipient, most researchers believed that the main functional anti-leukemia cells were T-cells, and donor CD3+ T-cells were found to interfere with survival after microtransplantation (38, 40).